RecruitingNCT05407480

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

Therapeutic Recommendations for Children Registered in the RFAOP Register and With a Hodgkin Lymphoma

Sponsor

French Africa Pediatric Oncology Group

Enrollment

250 participants

Start Date

Nov 15, 2022

Study Type

OBSERVATIONAL

Conditions

Staging Therapeutic Recommendations

Summary

The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.

Eligibility

Min Age: 0 MonthsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing treatment guidelines for children diagnosed with classical Hodgkin lymphoma — a type of blood cancer that affects the lymph nodes. The goal is to find the best treatment approach that balances effectiveness with minimizing long-term side effects in young patients. **You may be eligible if...** - You are under 18 years old at the time of diagnosis - You have been diagnosed with classical Hodgkin lymphoma (as defined by the WHO) - You have no prior history of blood cancers or immune deficiency conditions **You may NOT be eligible if...** - You are 18 or older at diagnosis - You have a previous blood cancer - You have a known immune deficiency (inherited or acquired) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.